Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.29M | 19.44M | -10.70M | -12.40M | -3.28M |
| Total Depreciation and Amortization | 37.19M | 44.69M | 21.76M | 43.88M | 30.57M |
| Total Amortization of Deferred Charges | 1.39M | 1.40M | 1.34M | 1.46M | 1.40M |
| Total Other Non-Cash Items | 117.00K | -2.80M | 6.69M | 6.53M | 10.42M |
| Change in Net Operating Assets | -24.65M | -11.99M | 3.39M | 938.00K | -23.35M |
| Cash from Operations | -11.26M | 50.74M | 22.49M | 40.40M | 15.76M |
| Capital Expenditure | -28.92M | -29.60M | -29.65M | -29.71M | -15.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 4.18M | 0.00 | -281.99M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.00M | 21.17M | 19.25M | -10.50M | -38.50M |
| Cash from Investing | -35.92M | -4.25M | -10.40M | -322.20M | -53.97M |
| Total Debt Issued | 54.40M | 35.40M | 21.80M | 58.80M | 370.50M |
| Total Debt Repaid | -15.24M | -39.94M | -41.54M | -90.54M | -15.10M |
| Issuance of Common Stock | 957.00K | 0.00 | 0.00 | 0.00 | 6.40M |
| Repurchase of Common Stock | -2.14M | -2.61M | -171.00K | -50.08M | -3.12M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.60M | 0.00 | 0.00 | -11.92M | -- |
| Cash from Financing | 35.38M | -7.15M | -19.92M | -93.75M | 358.68M |
| Foreign Exchange rate Adjustments | 4.53M | -8.12M | 7.75M | -1.13M | -4.96M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.27M | 31.22M | -79.00K | -376.67M | 315.50M |